Research comparison
BPC-157 vs TB-500
BPC-157 and TB-500 are two of the most-discussed peptides in tissue-repair research, and they are often mentioned together. They are not variants of one molecule: they differ in size, origin, and the cellular mechanism each is studied through. This page compares them on objective structure and research context, and links the pre-mixed blend for research designs that use both.
Side by side
| BPC-157 | TB-500 | |
|---|---|---|
| What it is | Synthetic pentadecapeptide (15 amino acids) | Thymosin beta-4 (43-amino-acid peptide) |
| Origin | Sequence derived from a protein found in gastric juice | Corresponds to an endogenous actin-binding protein |
| Molecular weight | ~1,419 g/mol | ~4,963 g/mol |
| Mechanism studied | Angiogenesis and growth-factor / nitric-oxide pathways | Actin regulation and cell migration |
| Common research focus | Tendon, ligament, muscle and gastrointestinal tissue models | Cardiac, dermal and vascular tissue models |
How they differ in research
BPC-157 is a small 15-amino-acid peptide whose sequence comes from a protein found in gastric juice. In research it is studied for tendon, ligament, muscle, and gastrointestinal tissue models, often through angiogenesis and growth-factor and nitric-oxide signalling.
TB-500 corresponds to thymosin beta-4, a much larger 43-amino-acid actin-binding peptide. Its research centres on actin regulation and cell migration, in cardiac, dermal, and vascular models.
Their mechanisms are different but their research contexts overlap in tissue biology, and a pre-mixed BPC-157 + TB-500 blend is available for research designs that use both materials.
Which suits which research question
Choose BPC-157 for research focused on tendon, ligament, muscle, or gastrointestinal tissue models; choose TB-500 for actin-regulation and cell-migration research in cardiac, dermal, or vascular models. For research designs that use both, the pre-mixed BPC-157 + TB-500 blend combines them in one vial. All are supplied for in-vitro laboratory research use only.
Frequently asked questions
Are BPC-157 and TB-500 the same thing?
No. They are different peptides: BPC-157 is a 15-amino-acid synthetic pentadecapeptide, while TB-500 corresponds to the 43-amino-acid thymosin beta-4. They are studied in the same tissue-repair context but through different mechanisms.
Why are BPC-157 and TB-500 studied together?
Their research mechanisms are complementary — BPC-157 is studied through angiogenesis and growth-factor pathways, TB-500 through actin regulation and cell migration — so tissue-repair research often examines them as a pair. A pre-mixed blend exists for this reason.
Which one should I choose for research?
It depends on the model: BPC-157 for tendon, ligament, muscle, and gastrointestinal tissue research; TB-500 for actin-regulation and cell-migration research. Both are supplied for laboratory research use only, each with a per-batch third-party COA.
This comparison describes objective compound pharmacology reported in the research literature. It is not medical guidance and makes no human efficacy, dosing, or therapeutic claims. All products are supplied by CertaPeptides (CERTALAB S.R.L.), a reseller, for laboratory research use only — not for human or animal consumption.